STOCKHOLDERS’ EQUITY |
3 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 5: STOCKHOLDERS’ EQUITY
Authorized Capital Stock
On June 19, 2024, our Board and Shareholders approved an increase in our authorized capital stock from shares of common stock, par value, to shares of common stock, no par value.
Common Stock
We are authorized to issue up to a total of shares of common stock, no par value per share. Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders, including the election of directors. Holders of our common stock have no cumulative voting rights. Further, holders of our common stock have no preemptive or conversion rights or other subscription rights.
Additionally, if a quorum is present, an action by stockholders entitled to vote on a matter is approved if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action (other than the election of directors). The vote of a majority of the shares of our common stock held by stockholders present in person or represented by proxy and entitled to vote at the Meeting will be sufficient to elect directors or to approve a proposal.
During the three months ended June 30, 2025, the Company issued an aggregate of shares of common stock for total proceeds of $3,935,522 pursuant to the April 2025 Offering, including partial exercise of the underwriter’s over-allotment option.
As of June 30, 2025, the total number of outstanding shares is .
Preferred Stock
The Company is not currently authorized to issue preferred stock under its Articles of Incorporation, but may choose to do so in the future.
|